Highnoon Laboratories Statistics

Total Valuation

Highnoon Laboratories has a market cap or net worth of PKR 39.79 billion. The enterprise value is 38.51 billion.

Market Cap	39.79B
Enterprise Value	38.51B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Apr 18, 2024

Share Statistics

Highnoon Laboratories has 52.98 million shares outstanding. The number of shares has increased by 0.00% in one year.

Shares Outstanding	52.98M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	41.30%
Owned by Institutions (%)	4.98%
Float	22.59M

Valuation Ratios

The trailing PE ratio is 14.01.

PE Ratio	14.01
Forward PE	n/a
PS Ratio	1.82
PB Ratio	3.96
P/FCF Ratio	12.33
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.36, with an EV/FCF ratio of 11.93.

EV / Earnings	13.56
EV / Sales	1.76
EV / EBITDA	9.36
EV / EBIT	10.11
EV / FCF	11.93

Financial Position

The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.11.

Current Ratio	3.20
Quick Ratio	1.66
Debt / Equity	0.11
Debt / EBITDA	0.27
Debt / FCF	0.35
Interest Coverage	16.51

Financial Efficiency

Return on equity (ROE) is 31.43% and return on invested capital (ROIC) is 23.05%.

Return on Equity (ROE)	31.43%
Return on Assets (ROA)	17.73%
Return on Capital (ROIC)	23.05%
Revenue Per Employee	9.54M
Profits Per Employee	1.24M
Employee Count	2,295
Asset Turnover	1.63
Inventory Turnover	2.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +99.94% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+99.94%
50-Day Moving Average	701.52
200-Day Moving Average	611.27
Relative Strength Index (RSI)	68.08
Average Volume (20 Days)	23,053

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Highnoon Laboratories had revenue of PKR 21.89 billion and earned 2.84 billion in profits. Earnings per share was 53.61.

Revenue	21.89B
Gross Profit	10.91B
Operating Income	3.81B
Pretax Income	3.83B
Net Income	2.84B
EBITDA	4.03B
EBIT	3.81B
Earnings Per Share (EPS)	53.61

Full Income Statement

Balance Sheet

The company has 2.40 billion in cash and 1.12 billion in debt, giving a net cash position of 1.28 billion or 24.21 per share.

Cash & Cash Equivalents	2.40B
Total Debt	1.12B
Net Cash	1.28B
Net Cash Per Share	24.21
Equity (Book Value)	10.05B
Book Value Per Share	189.73
Working Capital	7.31B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.62 billion and capital expenditures -395.97 million, giving a free cash flow of 3.23 billion.

Operating Cash Flow	3.62B
Capital Expenditures	-395.97M
Free Cash Flow	3.23B
FCF Per Share	60.91

Full Cash Flow Statement

Margins

Gross margin is 49.83%, with operating and profit margins of 17.40% and 12.98%.

Gross Margin	49.83%
Operating Margin	17.40%
Pretax Margin	17.52%
Profit Margin	12.98%
EBITDA Margin	18.41%
EBIT Margin	17.40%
FCF Margin	14.74%

Dividends & Yields

This stock pays an annual dividend of 30.00, which amounts to a dividend yield of 3.99%.

Dividend Per Share	30.00
Dividend Yield	3.99%
Dividend Growth (YoY)	72.50%
Years of Dividend Growth	11
Payout Ratio	56.19%
Buyback Yield	-0.00%
Shareholder Yield	3.99%
Earnings Yield	7.14%
FCF Yield	8.11%

Dividend Details

Stock Splits

The last stock split was on June 16, 2023. It was a forward split with a ratio of 1.15.

Last Split Date	Jun 16, 2023
Split Type	Forward
Split Ratio	1.15

Scores

Highnoon Laboratories has an Altman Z-Score of 6.88.

Altman Z-Score	6.88
Piotroski F-Score	n/a